On July 15, 2024, a panel of the Inquiry Committee approved a consent agreement between BCCNM and the registrant to address conduct and fitness concerns that occurred in 2022 relating to diversion of narcotics from the workplace, practising while impaired, diverting narcotics away from patients leaving them in discomfort, and falsification of records in order to conceal the diversion activities.
The registrant was diagnosed with and admitted to a disability with a causal relationship to the concerns via an independent medical evaluation and they have agreed to comply with the treatment recommendations and terms of a medical monitoring agreement. The registrant has voluntarily agreed to terms equivalent to limits and/or conditions on their practice, including:
a. A suspension of their nursing registration for one week;
b. Enrollment in a medical monitoring agreement with an independent medical monitoring agency for a minimum of 36 months with regular reports of compliance being provided to BCCNM;
c. Disclosure of treatment recommendations to relevant employer representative(s);
d. A limit restricting access to and handling of narcotics, benzodiazepines, controlled substances, and the “zed" class of drugs, with concurrent medical monitoring, for a term to support the stable return to work and ongoing fitness to practice;
e. A limit that they not work overtime, act as the nurse in charge, work night shifts, have supervision over students or be involved in the orientation of staff for a term;
f. Completion of an ethics course.
The agreement will remain in place for a minimum of four years of continuous nursing practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying a registrant or their personal health information respecting the condition that impaired their ability to practice nursing or midwifery.
The Inquiry Committee is satisfied that the terms will protect the public.